semaglutide patent expiry us 2031 Expiry: $6B India Pharma Growth Story Within weeks of the semaglutide

Rare but serious effectssuch as pancreatitis or thyroid-related issuesshould be discussed with your provider

Headaches: Some people report headaches when taking semaglutide

The warning reads: The following adverse reactions have been reported during post-approval use of semaglutide, the active ingredient of OZEMPIC

National Poison Center Trends in GLP-1 Receptor Agonist Exposures Following FDA Approval for Weight Loss

Conversely, sleep deprivation can lead to increased levels of your hunger hormone, causing more food cravings. The risk of muscle loss and sarcopenic obesity while taking GLP-1s is one reason Kumar stressed that people on these medications should be under the supervision of a medical expert and supported by a nutrition expert, such as a registered dietitian who can ensure they are meeting protein needs and avoiding health risks, she said

Caution should be exercised when treating these patients with Semaxen